Invest in

Fighting Fat

16.8%
5.5%
4.3%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
16.8%
5.5%
4.3%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
57.0% Diabetes Care 7.7%
19.4% Novo Nordisk A/S NVO 3.5%
16.4% Merck & Company Inc. (new) MRK 2.5%
14.8% Sanofi American Depositary Shares (Each repstg one-half of one) SNY 16.8%
2.8% Astrazeneca Plc ADR AZN 7.9%
1.9% Alkermes plc ALKS 33.4%
1.8% Greatbatch Inc. GB 41.2%
34.7% Weight Management 17.9%
13.1% NutriSystem Inc NTRI 1.5%
7.4% MEDIFAST INC MED 2.6%
4.5% Weight Watchers International Inc WTW 174.4%
3.3% Nu Skin Enterprises Inc. (A) NUS 1.1%
2.2% GNC Holdings Inc. Class A GNC 42.0%
2.1% Vitamin Shoppe Inc VSI 20.7%
2.0% USANA Health Sciences Inc. USNA 14.9%
8.3% Weight Loss Drugs 56.3%
8.3% Arena Pharmaceuticals Inc. ARNA 56.3%

Quotes delayed 15 mins. Currently Jun 26, 2016 11:15:37 AM. Fields are marked with -- when data is unavailable.